Angiotensin II-induced activation of central AT1 receptors exerts endocannabinoid-mediated gastroprotective effect in rats

Molecular and Cellular Endocrinology

Volumn 382, Issue 2, 2014, Pages 971-978

  Gyires, Klára ^a   Rónai, András Z ^a   Zádori, Zoltán S ^a   Tóth, Viktória E ^a   Németh, József ^b   Szekeres, Mária ^a   Hunyady, László ^a,c  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Angiotensin II; CB1 KO mice; Endocannabinoids; Gastroprotection; Rat

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; CANNABINOID 1 RECEPTOR; LIPOPROTEIN LIPASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH PROTECTION; STOMACH ULCER; VAGUS NERVE;

2-AG; 2-ARACHIDONOYLGLYCEROL; ANG II; ANGIOTENSIN AT(1) RECEPTOR; ANGIOTENSIN II; AT(1) RECEPTOR; CALCITONIN GENE-RELATED PEPTIDE; CB(1) KO MICE; CGRP; CHINESE HAMSTER OVARY; CHO; DAG; DAG LIPASE; DIACYLGLYCEROL; DIACYLGLYCEROL LIPASE; ENDOCANNABINOIDS; GASTROPROTECTION; RAT; TETRAHYDROLIPSTATIN; THL;

ANGIOTENSIN II; ANIMALS; ATROPINE; CHO CELLS; CRICETULUS; ETHANOL; GENE EXPRESSION REGULATION; INJECTIONS, INTRAVENTRICULAR; LACTONES; LIPOPROTEIN LIPASE; MALE; MICE; MICE, KNOCKOUT; PIPERIDINES; PYRAZOLES; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, CANNABINOID, CB1; SIGNAL TRANSDUCTION; STOMACH; STOMACH ULCER; VAGOTOMY; VAGUS NERVE;

EID: 84890290105     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2013.10.002     Document Type: Article

References (78)

1. Adami M., Frati P., Bertini S., Kulkarni-Narla A., Brown D.R., de Caro G., Coruzzi G., Soldani G. Gastric antisecretory role and immunohistochemical localization of cannabinoid receptors in the rat stomach. Br. J. Pharmacol. 2002, 135:1598-1606.
2. Adami M., Zamfirova R., Sotirov E., Tashev R., Dobrinova Y., Todorov S., Coruzzi G. Gastric antisecretory effects of synthetic cannabinoids after central or peripheral administration in the rat. Brain Res. Bull. 2004, 64:357-361.
3. Armando I., Seltzer A., Bregonzio C., Saavedra J.M. Stress and angiotensin II: novel therapeutic opportunities. Curr. Drug Targets CNS Neurol. Disord. 2003, 2:413-419.
4. Bakkali-Kassemi L., El Ouezzani S., Magoul R., Merroun I., Lopez-Jurado M., Errami M. Effects of cannabinoids on neuropeptide Y and β-endorphin expression in the rat hypothalamic arcuate nucleus. Br. J. Nutr. 2011, 105:654-660.
5. Basavarajappa B.S. Critical enzymes involved in endocannabinoid metabolism. Protein Pept. Lett. 2007, 14:237-246.
6. Bisogno T., Ligresti A., Di Marzo V. The endocannabinoid signalling system: biochemical aspects. Pharmacol. Biochem. Behav. 2005, 81:224-238.
7. Brancati S.B., Zádori Z.S., Németh J., Gyires K. Substance P induces gastric mucosal protection at supraspinal level via increasing the level of endomorphin-2 in rats. Brain Res. Bull. 2013, 91:38-45.
8. Bregonzio C., Armando I., Ando H., Jezova M., Baiardi G., Saavedra J.M. Anti-inflammatory effects of angiotensin II AT1 receptor antagonism prevent stress-induced gastric injury. Am. J. Physiol. Gastrointest. Liver Physiol. 2003, 285:414-423.
9. Brown A.J. Novel cannabinoid receptors. Br. J. Pharmacol. 2007, 152:567-575.
10. Castelli M.P., Piras A.P., Melis T., Succu S., Sanna F., Melis M.R., Collu S., Grazia E.M., Diaz G., Mackie K., Argiolas A. Cannabinoid CB1 receptors in the paraventricular nucleus and central control of penile erection: immunocytochemistry, autoradiography and behavioral studies. Neuroscience 2007, 147:197-206.
11. Casto R., Phillips M.I. Angiotensin II attenuates baroreflexes at nucleus tractus solitarius of rats. Am. J. Physiol. 1986, 250:193-198.
12. Chitravanshi V.C., Sapru H.N. Cardiovascular responses elicited by a new endogenous angiotensin in the nucleus tractus solitarius of the rat. Am. J. Physiol. Heart Circ. Physiol. 2011, 300:230-240.
13. De Souza H., Trajano E., de Carvalho F.V., Palermo N.J. Effects of acute and long-term cannabis treatment of restraint-induced gastric ulceration in rats. Jpn. J. Pharmacol. 1978, 28:507-510.
14. Dembinski A., Warzecha Z., Ceranowicz P., Dembinski M., Cieszkowski J., Pawlik W.W., Konturek S.J., Tomaszewska R., Hladki W., Konturek P.C. Cannabinoids in acute gastric damage and pancreatitis. J. Physiol. Pharmacol. 2006, 57(Suppl 5):137-154.
15. DeWire S.M., Ahn S., Lefkowitz R.J., Shenoy S.K. Beta-arrestins and cell signaling. Annu. Rev. Physiol. 2007, 69:483-510.
16. Di Marzo V. Targeting the endocannabinoid system: to enhance or reduce?. Nat. Rev. Drug Discov. 2008, 7:438-455.
17. Diz D.I., Barnes K.L., Ferrario C.M. Hypotensive actions of microinjections of angiotensin II into the dorsal motor nucleus of the vagus. J. Hypertens. Suppl. 1984, 2:53-56.
18. Diz D.I., Jessup J.A., Westwood B.M., Bosch S.M., Vinsant S., Gallagher P.E., Averill D.B. Angiotensin peptides as neurotransmitters/neuromodulators in the dorsomedial medulla. Clin. Exp. Pharmacol. Physiol. 2002, 29:473-482.
19. Fow J.E., Averill D.B., Barnes K.L. Mechanisms of angiotensin-induced hypotension and bradycardia in the medial solitary tract nucleus. Am. J. Physiol. 1994, 267:259-266.
20. Freund T.F., Katona I., Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev. 2003, 83:1017-1066.
21. Fujisawa Y., Nagai Y., Lei B., Nakano D., Fukui T., Hitomi H., Mori H., Masaki T., Nishiyama A. Roles of central renin-angiotensin system and afferent renal nerve in the control of systemic hemodynamics in rats. Hypertens. Res. 2011, 34:1228-1232.
22. Germano M.P., D'Angelo V., Mondello M.R., Pergolizzi S., Capasso F., Capasso R., Izzo A.A., Mascolo N., De Pasquale R. Cannabinoid CB1-mediated inhibition of stress-induced gastric ulcers in rats. Naunyn Schmiedebergs Arch. Pharmacol. 2001, 363:241-244.
23. Gonsiorek W., Lunn C., Fan X., Narula S., Lundell D., Hipkin R.W. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide. Mol. Pharmacol. 2000, 57:1045-1050.
24. Gregg L.C., Jung K.M., Spradley J.M., Nyilas R., Suplita R.L., Zimmer A., Watanabe M., Mackie K., Katona I., Piomelli D., Hohmann A.G. Activation of type 5 metabotropic glutamate receptors and diacylglycerol lipase-α initiates 2-arachidonoylglycerol formation and endocannabinoid-mediated analgesia. J. Neurosci. 2012, 32:9457-9468.
25. Gyires K. Morphine inhibits the ethanol-induced gastric damage in rats. Arch. Int. Pharmacodyn. Ther. 1990, 306:170-181.
26. Gyires K. Gastric mucosal protection: from prostaglandins to gene-therapy. Curr. Med. Chem. 2005, 12:203-215.
27. Gyires K., Rónai A.Z., Müllner K., Fürst S. Intracerebroventricular injection of clonidine releases beta-endorphin to induce mucosal protection in the rat. Neuropharmacology 2000, 39:961-968.
28. Gyombolai P., Pap D., Turu G., Catt K.J., Bagdy G., Hunyady L. Regulation of endocannabinoid release by G proteins: a paracrine mechanism of G protein-coupled receptor action. Mol. Cell Endocrinol. 2012, 353:29-36.
29. Holzer P., Pabst N.A., Lippe I.Th., Peskar B.M., Peskar B.A., Livingston E.H., Guth P.H. Afferent nerve-mediated protection against deep mucosal damage in the rat stomach. Gastroenterology 1990, 98:838-848.
30. Holzer P., Livingstone E.H., Saria A., Guth P.H. Sensory neurons mediate protective vasodilatation in rat gastric mucosa. Am. J. Physiol. 1991, 260:363-370.
31. Howlett A.C., Barth F., Bonner T.I., Cabral G., Casellas P., Devane W.A., Felder C.C., Herkenham M., Mackie K., Martin B.R., Mechoulam R., Pertwee R.G. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 2002, 54:161-202.
32. Hunyady L., Catt K.J. Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol. Endocrinol. 2006, 20:953-970.
33. Izzo A.A., Mascolo N., Capasso R., Germano M.P., De Pasquale R., Capasso F. Inhibitory effect of cannabinoid agonists on gastric emptying in the rat. Naunyn Schmiedebergs Arch. Pharmacol. 1999, 360:221-223.
34. Izzo A.A., Pinto L., Borrelli F., Capasso R., Mascolo N., Capasso F. Central and peripheral cannabinoid modulation of gastrointestinal transit in physiological states or during the diarrhoea induced by croton oil. Br. J. Pharmacol. 2000, 129:1627-1632.
35. Kato K., Yang H., Tache Y. Role of peripheral capsaicin-sensitive neurons and CGRP in central vagally mediated gastroprotective effect of TRH. Am. J. Physiol. 1994, 266:1610-1614.
36. Krowicki Z.K., Moerschbaecher J.M., Winsauer P.J., Digavalli S.V., Hornby P.J. Delta9-tetrahydrocannabinol inhibits gastric motility in the rat through cannabinoid CB1 receptors. Eur. J. Pharmacol. 1999, 371:187-196.
37. Kunos G., Osei-Hyiaman D., Bátkai S., Sharkey K.A., Makriyannis A. Should peripheral CB(1) cannabinoid receptors be selectively targeted for therapeutic gain?. Trends Pharmacol. Sci. 2009, 30:1-7.
38. Landi M., Croci T., Rinaldi-Carmona M., Maffrand J.P., Le Fur G., Manara L. Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB(1) receptors. Eur. J. Pharmacol. 2002, 450:77-83.
39. Lazary J., Juhasz G., Hunyady L., Bagdy G. Personalized medicine can pave the way for the safe use of CB1 receptor antagonists. Trends Pharmacol. Sci. 2011, 32:270-280.
40. Lefkowitz R.J. Historical review: a brief history and personal retrospective of seven-transmembrane receptors. Trends Pharmacol. Sci. 2004, 25:413-422.
41. Lenkei Z., Palkovits M., Corvol P., Llorens-Cortes C. Distribution of angiotensin type-1 receptor messenger RNA expression in the adult rat brain. Neuroscience 1998, 82:827-841.
42. Luoh H.F., Chan S.H. Participation of AT1 and AT2 receptor subtypes in the tonic inhibitory modulation of baroreceptor reflex response by endogenous angiotensins at the nucleus tractus solitarii in the rat. Brain Res. 1998, 782:73-82.
43. Mackie K. Distribution of cannabinoid receptors in the central and peripheral nervous system. Handb. Exp. Pharmacol. 2005, 168:299-325.
44. Makara J.K., Mor M., Fegley D., Szabo S.I., Kathuria S., Astarita G., Duranti A., Tontini A., Tarzia G., Rivara S., Freund T.F., Piomelli D. Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus. Nat. Neurosci. 2005, 8:1139-1141.
45. Marsicano G., Lutz B. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur. J. Neurosci. 1999, 11:4213-4225.
46. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990, 346:561-564.
47. Mayorov D.N. Brain angiotensin AT1 receptors as specific regulators of cardiovascular reactivity to acute psychoemotional stress. Clin. Exp. Pharmacol. Physiol. 2011, 38:126-135.
48. Michelini L.C., Bonagamba L.G. Angiotensin II as a modulator of baroreceptor reflexes in the brainstem of conscious rats. Hypertension 1990, 15:45-50.
49. Morsy M., Ashour O., Amin E., Rofaeil R. Gastroprotective effects of telmisartan on experimentally-induced gastric ulcers in rats. Pharmazie 2009, 64:590-594.
50. Mosqueda-Garcia R., Tseng C.J., Appalsamy M., Robertson D. Cardiovascular effects of microinjection of angiotensin II in the brainstem of renal hypertensive rats. J. Pharmacol. Exp. Ther. 1990, 255:374-381.
51. Munro S., Thomas K.L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993, 365:61-65.
52. Németh J., Görcs T., Helyes Zs., Oroszi G., Kocsy T., Pintér E., Szolcsányi J. Development of a new sensitive CGRP radioimmunoassay for neuropharmacological research. Neurobiology 1998, 6:473-475.
53. Németh J., Oroszi G., Jakab B., Magyarlaki M., Szilvássy Z., Roth E., Farkas B. 125I-labelling and purification of peptide hormones and bovine serum albumin. J. Radioanal. Nucl. Ch. 2002, 251:129-133.
54. Nishimura M., Ohtsuka K., Sakamoto M., Nanbu A., Takahashi H., Yoshimura M. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats. J. Hypertens. 1998, 16:1175-1185.
55. Pacher P., Bátkai S., Kunos G. Cardiovascular pharmacology of cannabinoids. Handb. Exp. Pharmacol. 2005, 168:599-625.
56. Pacher P., Batkai S., Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol. Rev. 2006, 58:389-462.
57. Partosoedarso E.R., Abrahams T.P., Scullion R.T., Moerschbaecher J.M., Hornby P.J. Cannabinoid1 receptor in the dorsal vagal complex modulates lower oesophageal sphincter relaxation in ferrets. J. Physiol. 2003, 550:149-158.
58. Pinto L., Izzo A.A., Cascio M.G., Bisogno T., Hospodar-Scott K., Brown D.R., Mascolo N., Di Marzo V., Capasso F. Endocannabinoids as physiological regulators of colonic propulsion in mice. Gastroenterology 2002, 123:227-234.
59. Piomelli D. The molecular logic of endocannabinoid signalling. Nat. Rev. Neurosci. 2003, 4:873-884.
60. Rettig R., Healy D.P., Printz M.P. Cardiovascular effects of microinjections of angiotensin II into the nucleus tractus solitarii. Brain Res. 1986, 364:233-240.
61. Rutkowska M., Fereniec-Goltbiewska L. ACEA (arachidonyl-2-chloroethylamide), the selective cannabinoid CB1 receptor agonist, protects against aspirin-induced gastric ulceration. Pharmazie 2006, 61:341-342.
62. Ryberg E., Larsson N., Sjogren S., Hjorth S., Hermansson N.O., Leonova J., Elebring T., Nilsson K., Drmota T., Greasley P.J. The orphan receptor GPR55 is a novel cannabinoid receptor. Br. J. Pharmacol. 2007, 152:1092-1101.
63. Saavedra J.M., Benicky J. Brain and peripheral angiotensin II play a major role in stress. Stress 2007, 10:185-193.
64. Saavedra J.M., Sanchez-Lemus E., Benicky J. Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications. Psychoneuroendocrinology 2011, 36:1-18.
65. Saperas E., Mourelle M., Santos J., Moncada S., Malagelada J.R. Central vagal activation by an analogue of TRH stimulates gastric nitric oxide release in rats. Am. J. Physiol. 1995, 268:895-899.
66. Seagard J.L., Dean C., Patel S., Rademacher D.J., Hopp F.A., Schmeling W.T., Hillard C.J. Anandamide content and interaction of endocannabinoid/GABA modulatory effects in the NTS on baroreflex-evoked sympathoinhibition. Am. J. Physiol. Heart Circ. Physiol. 2004, 286:992-1000.
67. Shujaa N., Zádori Z.S., Rónai A.Z., Barna I., Mergl Z., Mózes M.M., Gyires K. Analysis of the effect of neuropeptides and cannabinoids in gastric mucosal defense initiated centrally in the rat. J. Physiol. Pharmacol. 2009, 60(Suppl 7):93-100.
68. Sofia R.D., Diamantis W., Harrison J.E., Melton J. Evaluation of antiulcer activity of delta9-tetrahydrocannabinol in the Shay rat test. Pharmacology 1978, 17:173-177.
69. Steinberg B.A., Cannon C.P. Cannabinoid-1 receptor blockade in cardiometabolic risk reduction: safety, tolerability, and therapeutic potential. Am. J. Cardiol. 2007, 100:27-32.
70. Sugiura T., Kishimoto S., Oka S., Gokoh M. Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. Prog. Lipid Res. 2006, 45:405-446.
71. Tache Y. Brainstem neuropeptides and vagal protection of the gastric mucosal against injury: role of prostaglandins, nitric oxide and calcitonin-gene related peptide in capsaicin afferents. Curr. Med. Chem. 2012, 19:35-42.
72. Tiyerili V., Zimmer S., Jung S., Wassmann K., Naehle C.P., Lutjohann D., Zimmer A., Nickenig G., Wassmann S. CB1 receptor inhibition leads to decreased vascular AT1 receptor expression, inhibition of oxidative stress and improved endothelial function. Basic Res. Cardiol. 2010, 105:465-477.
73. Turu G., Simon A., Gyombolai P., Szidonya L., Bagdy G., Lenkei Z., Hunyady L. The role of diacylglycerol lipase in constitutive and angiotensin AT1 receptor-stimulated cannabinoid CB1 receptor activity. J. Biol. Chem. 2007, 282:7753-7757.
74. Turu G., Varnai P., Gyombolai P., Szidonya L., Offertaler L., Bagdy G., Kunos G., Hunyady L. Paracrine transactivation of the CB1 cannabinoid receptor by AT1 angiotensin and other Gq/11 protein-coupled receptors. J. Biol. Chem. 2009, 284:16914-16921.
75. Yoneda M., Tache Y. Vagal regulation of gastric prostaglandin E2 release by central TRH in rats. Am. J. Physiol. 1993, 264:231-236.
76. Zádori Z.S., Shujaa N., Köles L., Király K.P., Tekes K., Gyires K. Nocistatin and nociceptin given centrally induce opioid-mediated gastric mucosal protection. Peptides 2008, 29:2257-2265.
77. Zhang Y.M., Wei E.Q., Hu X., Qiao W.L., Shi Y., Xu M., Zhang J.F. The role of nuclear factor-kappaB in the effect of angiotensin II in the paraventricular nucleus in protecting the gastric mucosa from ischemia-reperfusion injury in rats. J. Gastroenterol. 2008, 43:687-698.
78. Zimmer A., Zimmer A.M., Hohmann A.G., Herkenham M., Bonner T.I. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc. Natl. Acad. Sci. USA 1999, 96:5780-5785.